Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8790 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-11-30

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the proportion of participants that initiate allergen immunotherapy (AIT) upon the recommendation of their physician and the proportion of participants that persist with their AIT throughout the recommended course.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

NCT04544774

Perennial Allergic Rhinitis Seasonal Allergic Rhinitis Local Allergic Rhinitis

RECRUITING

Impact of AIT on Allergic Rhinitis and Asthma

NCT04125888

Allergy Respiratory Disease

COMPLETED

Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study

NCT06778213

Allergic Rhinoconjunctivitis

RECRUITING PHASE4

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

NCT01085526

Allergic Rhinoconjunctivitis

COMPLETED NA

A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts

NCT01012752

Allergic Rhinitis Allergic Conjunctivitis

UNKNOWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Perennial Allergic Rhinitis Seasonal Allergic Rhinitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants with Allergic Rhinitis (AR)

Patients in a private allergy practice who were diagnosed with AR, with or without asthma, and advised to consider AIT between January 2005 and June 2011 and whose medical records were retrospectively reviewed.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of AR with or without allergic conjunctivitis (AC)
* Documented provider-to-patient or parent discussion of AIT as a treatment option

Exclusion Criteria

* Participants receiving AIT as an AR treatment without documented provider-to-patient or parent discussion of AIT as a treatment option
* Participants receiving immunotherapy for insect sensitivities only
* AIT started before 2005

Eligible Sex

ALL

Accepts Healthy Volunteers

No